RATIONALE: Higher mouse allergen levels in classrooms have been associated with increased asthma symptoms in students. This was demonstrated in a 5-year observational asthma school study. Two years after the conclusion of the study, a second asthma school study was launched in the same geographic area. We hypothesized that mouse allergen levels may have reduced between the 2 studies due to schools' self-motivation and improved pest reduction strategies. METHODS: The studies evaluated inner city, public elementary schools in the northeastern United States. Settled dust samples were collected from classrooms and analyzed for allergens, including mouse (Mus m 1). We used a mixed effects gamma model to determine the change in baseline mouse allergen levels between the observational study and the first 2 years of the second study. RESULTS: We observed a non-significant decrease in mouse allergen levels of 30% (p50.48) , and Tae-Bum Kim, MD, PhD 1 ; 1 Asan Medical Center, Seoul, Korea, Republic of (South), 2 Konkuk University Medical Center, Seoul, Korea, Republic of (South), 3 Mediplex Sejong Hospital, Seoul, Korea, Republic of (South). RATIONALE: Hypersensitivity reaction to iodinated contrast media (ICM) is a persistent clinical issue with the increased use of computed tomography. With the evidences indicating underlying allergic mechanisms, there have been studies regarding the skin tests using ICM. This study aimed to evaluate intradermal skin test (IDT) as a tool for preventing recurrent hypersensitivity reactions to ICM in the previous reactors. METHODS: Sixty-nine patients who had experienced immediate hypersensitivity reactions to ICM were included in the study. They all underwent IDT with 7 different ICM, including the causative one. We analyzed clinical data of the 38 patients who were re-exposed to the ICM, according to the results of IDT. RESULTS: Thirty-eight patients showed positive results to the culprit ICM (CULPRIT+) while 31 patients were negative (CULPRIT-). Sixteen patients from the CULPRIT+ group, and twenty-two from the CULPRITgroup were re-exposed to the ICM. In the CULPRIT+ group, when a patient used IDT-positive ICM as an alternative, 4 out of 5 experienced hypersensitivity reactions again. When a patient used IDT-negative ICM as an alternative, hypersensitivity reactions did not occur. In the CULPRITgroup, IDT-positive ICM did not provoke hypersensitivity reactions while 2 patients using IDT-negative ICM experienced hypersensitivity reactions. CONCLUSIONS: When the skin test is positive with culprit ICM, additional skin tests with other ICM are needed to select a safe alternative. If the skin test shows a negative result to the culprit ICM, changing the causative ICM to another one with premedication is important to prevent the recurrent hypersensitivity reactions. UT Southwestern Medical Center, Dallas, TX, 7 University Texas SW Medical Center, Dallas, TX. RATIONALE: Penicillin allergy testing successfully removes penicillin ''allergy'' in the majority of patients. However, prior studies have shown a frequency of 26-49% penicillin allergy relabeling after negative testing. This study evaluated the effect of several interventions to reduce the false relabeling of a penicillin ''allergy'' after negative testing. METHODS: Inpatients at Parkland Hospital were evaluated for penicillin allergy testing via a pharmacist-driven protocol. Those with negative testing had the penicillin allergy label removed from their chart and negative test results documented in a procedure note. Interventions in place to prevent relabeling included patient counseling from an inpatient penicillin pharmacist, a wallet card specifying non-allergy to penicillin, additional patient counseling during a post-discharge phone call, and a best-practice advisory in the electronic medical record. Finally, patients with a re-label of penicillin allergy had charts reviewed and providers contacted to determine if the re-label was false and if so, the EMR was corrected. RESULTS: Over a 3.5 year period, a total of 665 patients at Parkland Hospital were evaluated for inpatient penicillin allergy testing. Of the 627 who completed the protocol, 97.6% had their penicillin allergy removed. Of those with negative testing, 11.6% were relabeled with penicillin allergy. After individual chart review and contacting providers, the majority were able to have their penicillin allergy label removed once again, leaving an overall relabeling rate of 1.8%. CONCLUSIONS: This study shows that multiple interventions can significantly lower rates of false penicillin allergy relabeling. 
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